Rizatriptan
Back to searchMolecule Structure
Scientific Name
Rizatriptan
Description of the Drug
Rizatriptan is a 5-HT1B/1D receptor agonist used to treat migraines.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00953
http://www.drugbank.ca/drugs/DB00953
Brand Name(s)
Maxalt
Company Owner(s)
Alkem Laboratories Ltd, Jubilant Generics Ltd, Organon Llc, Macleods Pharmaceuticals Ltd, Invagen Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Emcure Pharmaceuticals Ltd, Aurobindo Pharma Ltd, Organon Llc A Sub Of Organon And Co, Glenmark Generics Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Serotonin 1b (5-HT1b) receptor | SINGLE PROTEIN | AGONIST | CHEMBL1898 |
Serotonin 1d (5-HT1d) receptor | SINGLE PROTEIN | AGONIST | CHEMBL1983 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL26662 | ||
PharmGKB | PA451264 | ||
Human Metabolome Database | HMDB0015088 | ||
DrugBank | DB00953 | ||
PubChem: Thomson Pharma | 15221855 | ||
PubChem | 5078 | ||
LINCS | LSM-3691 | ||
Nikkaji | J666.053C | ||
BindingDB | 50033437 | ||
EPA CompTox Dashboard | DTXSID2023565 | ||
DrugCentral | 2393 | ||
ChemicalBook | CB3245026 | ||
Guide to Pharmacology | 51 | ||
rxnorm | RIZATRIPTAN | RIZATRIPTAN BENZOATE | MAXALT |
ChEBI | 48273 | ||
ZINC | ZINC000000005895 |